Sign In
Buy AIM
$0.363
-0.0198 (-5.17%)
At Close: Jun 23, 2026
AIM Sports Group's National SoCal Cup ‘The Showcase' Event Serves Up a Weekend of New Experiences
02:24pm, Tuesday, 23'rd Jun 2026
LOS ANGELES--(BUSINESS WIRE)-- #aimsportsgroup--AIM Sports Group hosted the SoCal Cup ‘Showcase' tournament, one of the nation's leading tournament series for youth club volleyball, at the Los Angel
OUST's AIM Partnership Validates Rev8's Commercial Promise
11:01am, Tuesday, 23'rd Jun 2026
Ouster's AIM supply deal puts its Rev8 lidar into autonomous mining and construction fleets, offering a high-profile test of its commercial potential.
Metals One builds 5.57% stake in newly listed Talon Resources
03:04am, Tuesday, 23'rd Jun 2026
Metals One PLC (AIM:MET1, FRA:HT7, OTCQB:MTOPF), the gold and uranium developer and investor, has built a 5.57% stake in Talon Resources. The holding was confirmed as Talon began trading on AIM on Tu
Cavendish backs CelLBxHealth turnaround with buy rating, 4p target
10:35am, Monday, 22'nd Jun 2026
Cavendish remains bullish on CelLBxHealth PLC (AIM:CLBX, FRA:DWV) with a 'buy' rating and 4p price target in the wake of its prelims earlier. The AIM-listed biotech has completed a strategic reset c
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series
08:45am, Monday, 22'nd Jun 2026
OCALA, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it will present in the Webull Corporate Connect Webinar S
CelLBxHealth guides for 50% revenue growth as partnership pipeline swells
03:01am, Monday, 22'nd Jun 2026
CelLBxHealth PLC (AIM:CLBX, FRA:DWV), the circulating tumour cell diagnostics company, expects revenues of at least £2.1 million in 2026, representing growth of at least 50% from last year's £1.4 mi
Union Jack Oil 's Crossroads well disappoints with non-commercial result
03:35am, Friday, 19'th Jun 2026
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) said its Crossroads well in Garvin County, Oklahoma, has been deemed non-commercial following testing, marking a setback for the AIM-listed company'
Study results expected to support design and initiation of a pivotal Phase 3 clinical trial in the treatment of metastatic pancreatic cancer Study results expected to support design and initiation of
Bet on 5 Top-Ranked Stocks With Rising P/E for Solid Returns
09:00am, Thursday, 18'th Jun 2026
Rising P/E ratios can signal confidence and momentum. Discover 5 stocks backed by strong earnings growth and upside potential.
AIM Talks China 2026 Convenes in Guangzhou, Advancing Strategic Partnerships and Cross Border Investment Across the Greater Bay Area
04:15am, Wednesday, 17'th Jun 2026
GUANGZHOU, China , June 17, 2026 (GLOBE NEWSWIRE) -- As global capital, industrial transformation, and cross border trade realign around new growth corridors, AIM Talks China 2026 convened investors,
Optima Health trading 'in line' as it continues to grow UK and Ireland platform
03:10am, Tuesday, 16'th Jun 2026
Optima Health PLC (AIM:OPT, OTC:OHLTF, FRA:J3N) said full-year revenue rose around 15% to approximately £121 million for the year ended 31 March 2026, in line with market expectations, as the occupat
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
08:01am, Monday, 15'th Jun 2026
OCALA, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM,” or the “Company”), an immuno-pharma company focused on the development of therapeutics to treat
Union Jack Oil reveals takeover approach by Reabold Resources
02:33am, Monday, 15'th Jun 2026
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) announced it has received a non-binding approach from Reabold Resources PLC (AIM:RBD, FRA:AWL1) over a possible all-share takeover. The AIM-listed o
Infosys Collaborates with CMMI Institute to Shape Enterprise AI Maturity Framework; Achieves Milestone Recognition
08:00am, Thursday, 11'th Jun 2026
Infosys Collaborates with CMMI Institute to Shape Enterprise AI Maturity Framework; Achieves Milestone Recognition PR Newswire
Infosys Collaborates with CMMI Institute to Shape Enterprise AI Maturity Framework; Achieves Milestone Recognition
07:23am, Thursday, 11'th Jun 2026
As a pilot participant, Infosys contributed to shaping the CMMI AI Maturity (AIM) framework – bringing enterprise-scale AI practices, governance models, and real-world deployment insights – powere
